The list of the worst biopharma CEOs of 2022: No ‘winner,’ just accountability

I enjoy thinking about and writing the Worst CEOs of Biopharma column every year. It’s not because I’m mean or vindictive. This list is about holding people and an industry accountable. It’s a public service!

Let me know in the comments or on Twitter if I missed the mark, or, more importantly, if I forgot a deserving “naughty” CEO.

Clay Siegall, Seagen

I don’t normally let a CEO’s personal problems factor into this list, but Clay Siegall leaves me no choice. In May, he was forced out of Seagen after his arrest on charges of allegedly assaulting his wife at their suburban Seattle mansion.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe

Log In